Publications by authors named "Olof Selroos"

Claim this Profile
I
Inhaled budesonide and pulmonary sarcoidosis revisited.
Olof Selroos, Ralph Brattsand

Sarcoidosis Vasc Diffuse Lung Dis· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Budesonide Attains Its Wide Clinical Profile by Alternative Kinetics.
Ralph Brattsand, Olof Selroos

Pharmaceuticals (Basel)· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
May a different kinetic mode explain the high efficacy/safety profile of inhaled budesonide?
Ralph Brattsand, Olof Selroos

Pulm Pharmacol Ther· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exome Sequencing Identifies Susceptibility Loci for Sarcoidosis Prognosis.
Elisa Lahtela, Matti Kankainen, Juha Sinisalo, Olof Selroos, Marja-Liisa Lokki

Front Immunol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
gene variants and sarcoidosis in a Finnish population.
Elisa Lahtela, Annika Wennerström, Anne Pietinalho, Martin Petrek, Vitezslav Kolek, Olof Selroos

Sarcoidosis Vasc Diffuse Lung Dis· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SNP Variants in Major Histocompatibility Complex Are Associated with Sarcoidosis Susceptibility-A Joint Analysis in Four European Populations.
Annika Wolin, Elisa Laura Lahtela, Verneri Anttila, Martin Petrek, Johan Grunewald, Olof Selroos

Front Immunol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Finnish experience to save asthma costs by improving care in 1987-2013.
Tari Haahtela, Fredrik Herse, Jussi Karjalainen, Timo Klaukka, Miika Linna, Olof Selroos

J Allergy Clin Immunol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics of reversible and nonreversible COPD and asthma and COPD overlap syndrome patients: an analysis of salbutamol Easyhaler data.
Veronika Müller, Gabriella Gálffy, Márta Orosz, Zsuzsanna Kováts, Balázs Odler, Olof Selroos

Int J Chron Obstruct Pulmon Dis· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
National and regional asthma programmes in Europe.
Olof Selroos, Maciej Kupczyk, Piotr Kuna, Piotr Łacwik, Jean Bousquet

Eur Respir Rev· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Revisiting early intervention in adult asthma.
Tari Haahtela, Olof Selroos, Paul M O'Byrne

ERJ Open Res· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dry-powder inhalers in acute asthma.
Olof Selroos

Ther Deliv· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhaler competence and patient satisfaction with Easyhaler®: results of two real-life multicentre studies in asthma and COPD.
Gabriella Gálffy, Györgyi Mezei, Gyula Németh, Lilla Tamási, Veronika Müller, Olof Selroos

Drugs R D· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Major histocompatibility complex class II and BTNL2 associations in sarcoidosis.
Annika Wennerström, Anne Pietinalho, Jagoda Lasota, Krista Salli, Ida Surakka, Olof Selroos

Eur Respir J· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuous versus intermittent inhaled corticosteroid (budesonide) for mild persistent asthma in children--not too much, not too little.
Markku Turpeinen, Anna S Pelkonen, Olof Selroos, Kurt Nikander, Tari Haahtela

Thorax· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Do asthmatic smokers benefit as much as non-smokers on budesonide/formoterol maintenance and reliever therapy? Results of an open label study.
Onno C P van Schayck, John Haughney, Michel Aubier, Olof Selroos, Tommy Ekström

Respir Med· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HLA-DRB1 allele frequencies and C4 copy number variation in Finnish sarcoidosis patients and associations with disease prognosis.
Annika Wennerström, Anne Pietinalho, Hanna Vauhkonen, Laura Lahtela, Anil Palikhe, Olof Selroos

Hum Immunol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is the patient's baseline inhaled steroid dose a factor for choosing the budesonide/formoterol maintenance and reliever therapy regimen?
Michel Aubier, John Haughney, Olof Selroos, Onno C P van Schayck, Tommy Ekström

Ther Adv Respir Dis· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone mineral density in children treated with daily or periodical inhaled budesonide: the Helsinki Early Intervention Childhood Asthma study.
Markku Turpeinen, Anna S Pelkonen, Kurt Nikander, Ritva Sorva, Olof Selroos

Pediatr Res· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Skin thickness in children treated with daily or periodical inhaled budesonide for mild persistent asthma. The Helsinki early intervention childhood asthma study.
Markku Turpeinen, Hanna Raitio, Anna S Pelkonen, Kurt Nikander, Ritva Sorva, Olof Selroos

Pediatr Res· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thirteen-year follow-up of early intervention with an inhaled corticosteroid in patients with asthma.
Tari Haahtela, Klaus Tamminen, Tuomo Kava, L Pekka Malmberg, Paula Rytilä, Olof Selroos

J Allergy Clin Immunol· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of dry powder inhalers in acute exacerbations of asthma and COPD.
Olof Selroos, Lars Borgström, Jarl Ingelf

Ther Adv Respir Dis· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Budesonide/formoterol as effective as prednisolone plus formoterol in acute exacerbations of COPD. A double-blind, randomised, non-inferiority, parallel-group, multicentre study.
Björn Ställberg, Olof Selroos, Claus Vogelmeier, Eva Andersson, Tommy Ekström

Respir Res· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ophthalmologic findings in children with asthma receiving inhaled budesonide.
Anna Pelkonen, Osmo Kari, Olof Selroos, Kurt Nikander, Tari Haahtela

J Allergy Clin Immunol· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of disease duration on dose-response of inhaled budesonide in asthma.
Olof Selroos

Respir Med· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A smarter way to manage asthma with a combination of a long-acting beta(2)-agonist and inhaled corticosteroid.
Olof Selroos

Ther Clin Risk Manag· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis